Efficacy of an Education Program for People With Diabetes and Insulin Pump Treatment (INPUT): Results From a Randomized Controlled Trial

被引:31
|
作者
Ehrmann, Dominic [1 ,2 ]
Kulzer, Bernhard [1 ,2 ,3 ]
Schipfer, Melanie [1 ]
Lippmann-Grob, Bernhard [3 ]
Haak, Thomas [3 ]
Hermanns, Norbert [1 ,2 ,3 ]
机构
[1] Res Inst Diabet Acad Mergentheim, Bad Mergentheim, Germany
[2] Univ Bamberg, Dept Clin Psychol & Psychotherapy, Bamberg, Germany
[3] Diabet Clin Mergentheim, Bad Mergentheim, Germany
关键词
THERAPY; DISTRESS; MELLITUS; ADULTS; ADOLESCENTS; SYMPTOMS; DELIVERY; INFUSION;
D O I
10.2337/dc18-0917
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Continuous subcutaneous insulin infusion (CSII) is the most advanced form of insulin delivery, but it requires structured education to provide users with the necessary knowledge/skills and to support their motivation. Currently, no structured education program designed to provide this training has been evaluated. We developed a CSII-specific, structured education program (Insulin Pump Treatment [INPUT]) and evaluated its impact on glycemic control, behavior, and psychosocial status. RESEARCH DESIGN AND METHODS This was a multicenter, randomized, parallel trial with a 6-month follow-up. Eligible participants (age 16-75 years) currently were treated with insulin pump therapy. Participants were randomly assigned (1:1) to the INPUT program or to usual care using a computer-generated algorithm, with study center as the stratification factor. The primary outcome was HbA(1c) change from baseline to 6 months. Secondary outcomes were incidence of severe hypoglycemia and changes in behavioral and psychosocial measures. RESULTS Between 1 April 2016 and 26 April 2016, 268 people with diabetes and a mean duration of CSII therapy of 9.5 years were randomly assigned to the INPUT group (n = 135) or control group (n = 133). At 6 months, HbA(1c) improved in the INPUT group (8.33 +/- 0.8 vs. 8.04 +/- 0.9; P < 0.0001) but not in the control group (8.33 +/- 1.0 vs. 8.27 +/- 1.0; P = 0.11). The between-group difference in HbA(1c) reduction was significant, favoring INPUT (-0.28% vs. -0.06%, Delta -0.22%, 95% CI -0.38 to -0.06; P = 0.0029). The incidence rate ratio of severe hypoglycemia was 3.55 times higher for participants in the control group than for those in the INPUT group (95% CI 1.50-8.43; P = 0.0041). CONCLUSIONS The INPUT education program led to a significant improvement in glycemic control and incidence of severe hypoglycemia in insulin pump users.
引用
收藏
页码:2453 / 2462
页数:10
相关论文
共 50 条
  • [1] Comparison of the efficacy of an education program for people with diabetes and insulin pump treatment (INPUT) in a randomized controlled trial setting and the effectiveness in a routine care setting: Results of a comparative effectiveness study
    Bergis, Dominik
    Ehrmann, Dominic
    Albrecht, Carmen
    Haak, Thomas
    Kulzer, Bernhard
    Hermanns, Norbert
    [J]. PATIENT EDUCATION AND COUNSELING, 2019, 102 (10) : 1868 - 1874
  • [2] Structured self-management education for insulin pump therapy (INPUT): results from a randomised controlled trial
    Ehrmann, D.
    Kulzer, B.
    Schipfer, M.
    Lippmann-Grob, B.
    Haak, T.
    Hermanns, N.
    [J]. DIABETOLOGIA, 2018, 61 : S30 - S30
  • [3] Efficacy of DiaLife, an Education Program for Relatives of Adults with Diabetes-A Cluster Randomized Controlled Trial
    Bernard, Marie
    Lehmann, Thomas
    Hecht, Lars
    Fabisch, Gottlobe
    Harder, Asja
    Mueller, Nicolle
    Luck-Sikorski, Claudia
    [J]. PATIENT EDUCATION AND COUNSELING, 2022, 105 (07) : 2158 - 2165
  • [4] Who benefits most from diabetes education? Results of a randomized controlled trial
    Piatt, G
    Anderson, RM
    Simmons, D
    Siminerio, L
    Zgibor, JC
    [J]. DIABETES, 2004, 53 : A90 - A90
  • [5] Who benefits most from diabetes education? Results of a randomized controlled trial.
    Piatt, GA
    Anderson, RM
    Simmons, D
    Siminerio, LM
    Zgibor, JC
    [J]. DIABETES, 2004, 53 : A220 - A220
  • [6] Efficacy and safety of liraglutide in insulin pump treated people with type 1 diabetes: the lira pump trial
    Dejgaard, T. F.
    Frandsen, C. S.
    Schmidt, S.
    Vistisen, D.
    Madsbad, S.
    Andersen, H. U.
    Norgaard, K.
    [J]. DIABETOLOGIA, 2017, 60 : S70 - S70
  • [7] Efficacy of a Digital Diabetes Logbook for Reducing Treatment Burden-Results of a Randomized Controlled Trial
    Ehrmann, Dominic
    Hermanns, Norbert
    Silbermann, Stephan
    Kober, Johanna
    Finke-Groene, Katharina
    Roos, Timm
    Vesper, Iris
    Schaefer, Vanessa L.
    Kulzer, Bernhard
    [J]. DIABETES, 2023, 72
  • [8] TRANSITION FROM INSULIN PUMP TO MULTIPLE DAILY INJECTIONS USING INSULIN DEGLUDEC: INTERIM RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
    Shah, V.
    Vigers, T.
    Snell-Bergeon, J.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A195 - A195
  • [9] Mobile Delivery of the Diabetes Prevention Program in People With Prediabetes: Randomized Controlled Trial
    Toro-Ramos, Tatiana
    Michaelides, Andreas
    Anton, Maria
    Karim, Zulekha
    Kang-Oh, Leah
    Argyrou, Charalambos
    Loukaidou, Elisavet
    Charitou, Marina M.
    Sze, Wilson
    Miller, Joshua D.
    [J]. JMIR MHEALTH AND UHEALTH, 2020, 8 (07):
  • [10] A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes
    Fox, LA
    Wysocki, T
    Buckloh, LM
    Mauras, N
    Smith, SD
    [J]. DIABETES CARE, 2005, 28 (06) : 1277 - 1281